The CR1 gene, implicated in complement activation, is believed to exert its role to AD pathogenesis through amyloid-β clearance, neuroinflammation and tauopathy (the deposition of abnormal tau protein in the brain)64. This evidence concerns the gene CR1 and tauopathy.